Laurus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LAURUS, and what generic and branded alternatives to LAURUS drugs are available?
LAURUS has fifteen approved drugs.
There are seven tentative approvals on LAURUS drugs.
Drugs and US Patents for Laurus
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laurus | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 214513-002 | Jan 22, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | LOPINAVIR AND RITONAVIR | lopinavir; ritonavir | TABLET;ORAL | 213857-001 | Mar 21, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | LOPINAVIR AND RITONAVIR | lopinavir; ritonavir | TABLET;ORAL | 213857-002 | Mar 21, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 209882-002 | Aug 27, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 209882-003 | Aug 27, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Laurus | GABAPENTIN | gabapentin | TABLET;ORAL | 217965-002 | Apr 8, 2024 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.